WG Tech(SH:603773) Chang Jiang Shang Bao·2026-02-06 00:12Core Viewpoint - The company, Woge Optoelectronics, faced regulatory warnings due to misleading disclosures regarding its involvement in commercial aerospace and brain-computer interface sectors, which led to a temporary stock price surge followed by a decline after clarifications were made [1][5]. Group 1: Regulatory Actions - On February 2, Woge Optoelectronics provided inaccurate and incomplete information regarding its CPI aerospace applications and microfluidic biochip products, prompting the Shanghai Stock Exchange to issue a regulatory warning to the company's then-secretary of the board, Gong Qingyu [1][2]. - Following regulatory pressure, the company clarified that its CPI products had not yet achieved mass production and that previous claims about its industry position were based on its own assessments rather than third-party validation [3][4]. Group 2: Financial Performance - Woge Optoelectronics has reported continuous losses since 2021, with cumulative losses exceeding 580 million yuan by 2025, and is projected to incur a net loss of 100 to 140 million yuan in 2025 [1][7]. - The company’s revenue has shown a gradual increase from 1.05 billion yuan in 2021 to an expected 2.4 to 2.7 billion yuan in 2025, indicating a growth trend despite ongoing losses [7][8]. Group 3: Business Segments - The company's operations are divided into three main segments: traditional glass processing for display panels, new display technologies including glass-based Mini LED and Micro LED products, and glass-based circuit boards for the semiconductor industry [6][8]. - Woge Optoelectronics is focusing on enhancing its core capabilities and market share in existing businesses while facing challenges related to increased R&D and management costs due to new product development and production line construction [8].